Truvada Tablet, Film Coated
Product Images NDC 61958-0704

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Truvada (NDC 61958-0704). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gilead Sciences, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Truvada 01)

Chemical structure diagram depicting the active ingredient emtricitabine, part of the combination in Truvada (emtricitabine and tenofovir disoproxil fumarate). The structure shows atoms and bonds representing the molecule's configuration.*

FDA Label Image

Chemical Structure (Truvada 02)

Chemical structure of emtricitabine and tenofovir disoproxil fumarate, the active ingredients in the prescription drug Truvada.*

FDA Label Image

Principal Display Panel (30 Tablet Bottle Label)

Label for Truvada tablets containing 200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate per tablet. The film-coated tablets come in a bottle of 30 tablets. Manufactured for Gilead Sciences, Inc., the label includes storage instructions and dispensing information.*

FDA Label Image

Principal Display Panel (100 mg/150 mg Tablet Bottle Label)

Label for Truvada tablets containing 100 mg emtricitabine and 150 mg tenofovir disoproxil fumarate, film-coated oral tablets. The label specifies the package contains 30 tablets and is manufactured for Gilead Sciences, Inc. The NDC number 61958-0703-1 is displayed, with storage and dispensing instructions included on the label.*

FDA Label Image

Principal Display Panel (133 mg/200 mg Tablet Bottle Label)

Label for Truvada tablets containing 133 mg emtricitabine and 200 mg tenofovir disoproxil fumarate. This oral film-coated tablet packaging shows 30 tablets per container, manufactured for Gilead Sciences, Inc. Storage instructions and dispensing warnings are included on the label.*

FDA Label Image

Principal Display Panel (167 mg/250 mg Tablet Bottle Label)

Label for Truvada tablets containing emtricitabine 167 mg and tenofovir disoproxil fumarate 250 mg. The film-coated oral tablets come in a package of 30, manufactured for Gilead Sciences, Inc., Foster City, CA, made in Canada. The label includes storage instructions and a reminder to dispense with the Medication Guide.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.